LYMS:F:F-Lyxor UCITS Nasdaq-100 D-EUR (EUR)

ETF | Others |

Last Closing

USD 83.8

Change

0.00 (0.00)%

Market Cap

N/A

Volume

5.92K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.13 (-0.47%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.22 (-0.41%)

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.38 (+0.06%)

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.17 (-0.30%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.08 (-0.51%)

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.75 (-0.71%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

-0.29 (-0.26%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.20 (+0.18%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.10 (-1.26%)

USD 38.52B
0ZC:F Zscaler Inc

+3.64 (+2.07%)

USD 37.92B

ETFs Containing LYMS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.76% 78% C+ 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.76% 77% C+ 58% F
Trailing 12 Months  
Capital Gain 40.30% 94% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.30% 92% A 74% C
Trailing 5 Years  
Capital Gain 170.98% 99% N/A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 170.98% 99% N/A 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 21.11% 95% A 82% B
Dividend Return 21.11% 93% A 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.04% 20% F 64% D
Risk Adjusted Return 100.36% 93% A 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.